Cases

The DEA's temporary pandemic-era rule allowing telehealth prescribing of controlled substances (e.g., stimulants for ADHD, benzodiazepines for anxiety) without an in-person visit is set to expire, but pressure mounts to extend or make it permanent. Startups like Cerebral and Done have scaled ADHD care virtually, increasing access but also drawing scrutiny for overprescribing. In 2024, the DEA proposed a hybrid model requiring one in-person visit, but mental health advocates argue this creates barriers for rural, disabled, or low-income patients. Meanwhile, data shows a 300% increase in stimulant prescriptions since 2020, raising concerns about diversion and misuse. This trial confronts the tension between expanding access to critical mental health medications and ensuring appropriate diagnostic rigor and safety monitoring.

Direct-to-consumer gut microbiome tests (e.g., Viome, Thryve, Ombre) promise personalized nutrition advice based on stool analysis, claiming to identify dysbiosis, recommend probiotics, and tailor diets for inflammation, bloating, or metabolic health. However, the scientific validity of these services is contested. While research confirms the gut microbiome's role in health, clinical utility of commercial tests remains unproven. Most lack FDA oversight, use inconsistent methodologies, and offer recommendations not grounded in robust evidence. A 2024 review in Nature Microbiology highlighted poor reproducibility and weak correlation between test results and clinical outcomes. Yet consumers spend millions annually seeking answers for chronic digestive issues. This raises questions about whether these tests empower informed choices or exploit health anxiety with pseudoscientific claims.

GLP-1 receptor agonists like semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) have revolutionized weight management, originally approved for type 2 diabetes and later for obesity (BMI ≥30 or ≥27 with comorbidities). However, demand has surged among individuals with normal or overweight BMI seeking aesthetic or metabolic benefits. Clinicians report increasing off-label requests, while shortages have impacted diabetic patients. The FDA has not approved these drugs for cosmetic weight loss, and long-term safety data in non-obese populations is limited. Ethical concerns include medicalization of normal body variation, reinforcement of weight stigma, and diversion of scarce resources. Meanwhile, proponents argue that metabolic health isn't solely determined by BMI and that early intervention may prevent future disease. This dilemma forces a reckoning between patient autonomy, equitable access, and evidence-based boundaries in weight management.

The CDC recommends HPV vaccination up to age 45 based on shared clinical decision-making, but not as routine due to presumed prior exposure. However, new data shows many adults over 45 remain HPV-naïve, especially those with limited sexual partners or in new relationships. Gardasil-9 prevents cancers of the cervix, oropharynx, anus, and penis, yet vaccination rates in this group are below 5%. Some clinicians advocate proactive offering, while insurers often deny coverage, citing 'low benefit.' A 2024 study in JAMA Internal Medicine found significant seronegativity in adults 45–65, suggesting missed prevention opportunities. This raises ethical and practical questions: Should age-based cutoffs override individual risk assessment? And does cost-effectiveness analysis undervalue cancer prevention in midlife adults?

Senolytics—compounds that selectively clear senescent 'zombie' cells—have shown promise in animal studies for extending healthspan and treating age-related diseases. Early human trials with dasatinib + quercetin or fisetin suggest potential benefits for frailty, osteoarthritis, and pulmonary fibrosis. However, these drugs are not FDA-approved for longevity, and long-term safety data is absent. Despite this, biohackers and functional medicine clinics are offering off-label senolytic regimens, often combining unregulated supplements with prescription drugs. A 2025 review in Aging Cell cautions that premature adoption risks unknown side effects, including impaired wound healing or immune disruption. Yet advocates argue that waiting decades for phase III trials denies proactive individuals access to cutting-edge science. This trial examines whether the current evidence justifies clinical or self-directed use.

AI-powered relationship apps now offer real-time communication feedback, conflict de-escalation scripts, and attachment style analysis based on user input. While these tools increase access to support, especially in underserved areas, concerns are rising about accuracy, emotional safety, and ethical boundaries. Can an algorithm truly understand nuanced dynamics like coercive control or cultural differences in conflict expression? Recent incidents include AI coaches normalizing abusive behavior or giving generic advice that worsens anxiety. The debate centers on whether AI should be limited to psychoeducation—or if real-time coaching requires human supervision to avoid harm.

A growing debate in the psychotherapy community centers on therapist self-disclosure, particularly regarding attachment styles. With Emotionally Focused Therapy (EFT) and other modalities emphasizing the therapeutic alliance as a corrective emotional experience, some clinicians argue that sharing their own secure (or formerly insecure) attachment history can normalize vulnerability and model earned security. Others caution that such disclosures may blur professional boundaries, shift focus away from the client, or unintentionally influence client narratives. This question is especially relevant as more therapists integrate personal development into their professional identity, and as clients increasingly seek 'relatable' practitioners on social media. The stakes involve ethical practice, therapeutic efficacy, and the evolving definition of transparency in mental health care.

As awareness of trauma and mental health grows, many daters now share significant personal histories—such as childhood abuse, addiction recovery, or past relationship violence—within the first few conversations. While some view this as authentic vulnerability that fosters connection, others label it 'trauma dumping': overwhelming a new partner with unprocessed pain without consent or reciprocity. This dilemma reflects broader cultural tensions between emotional openness and boundary respect. The rise of 'trauma-informed dating' on social media complicates norms: is early disclosure a sign of self-awareness or poor emotional regulation? The stakes involve emotional safety, consent in emotional labor, and the risk of retraumatization for both parties.

Many therapists now recommend or require individual sessions before starting couples therapy, especially when there's a history of conflict, infidelity, or power imbalances. Proponents argue that individual work allows each partner to explore personal patterns, attachment wounds, and goals without performance pressure or fear of retaliation. Critics worry this delays relational healing, increases cost and time burden, and may reinforce individualistic rather than systemic thinking. This question is timely as teletherapy expands access and clients seek faster results. The decision impacts therapeutic efficacy, equity (due to cost), and whether underlying individual issues like untreated anxiety or trauma are addressed before attempting relational repair.

In response to app-driven dating fatigue, the 'slow love' movement advocates delaying physical intimacy, minimizing texting, and prioritizing in-person connection to foster secure attachment. Backed by attachment theory, proponents argue that rushing intimacy triggers anxious or avoidant cycles. Critics counter that 'slow love' can reinforce traditional gender roles, ignore neurodivergent communication needs, or become a form of control disguised as mindfulness. With dating app usage at an all-time high and reported satisfaction at a low, this approach is gaining traction—but is it inclusive and evidence-based? The stakes involve emotional safety, autonomy, and whether pacing rules help or hinder authentic connection.